FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q33165430> ?p ?o ?g. }

• Q33165430 description "2015 nî lūn-bûn" @default.
• Q33165430 description "2015 թուականի Մարտին հրատարակուած գիտական յօդուած" @default.
• Q33165430 description "2015 թվականի մարտին հրատարակված գիտական հոդված" @default.
• Q33165430 description "2015年の論文" @default.
• Q33165430 description "2015年論文" @default.
• Q33165430 description "2015年論文" @default.
• Q33165430 description "2015年論文" @default.
• Q33165430 description "2015年論文" @default.
• Q33165430 description "2015年論文" @default.
• Q33165430 description "2015年论文" @default.
• Q33165430 description "2015年论文" @default.
• Q33165430 description "2015年论文" @default.
• Q33165430 description "2015年论文" @default.
• Q33165430 description "2015年论文" @default.
• Q33165430 description "2015年论文" @default.
• Q33165430 description "2015년 논문" @default.
• Q33165430 description "article científic" @default.
• Q33165430 description "article scientific" @default.
• Q33165430 description "article scientifique (publié 2015)" @default.
• Q33165430 description "articol științific" @default.
• Q33165430 description "articolo scientifico" @default.
• Q33165430 description "artigo científico (publicado na 2015)" @default.
• Q33165430 description "artigo científico (publicado na 2015)" @default.
• Q33165430 description "artigo científico" @default.
• Q33165430 description "artikull shkencor" @default.
• Q33165430 description "artikulong pang-agham" @default.
• Q33165430 description "artykuł naukowy" @default.
• Q33165430 description "artículo científico publicado en 2015" @default.
• Q33165430 description "artículu científicu espublizáu en 2015" @default.
• Q33165430 description "bilimsel makale" @default.
• Q33165430 description "bài báo khoa học" @default.
• Q33165430 description "mokslinis straipsnis" @default.
• Q33165430 description "naučni članak" @default.
• Q33165430 description "scienca artikolo" @default.
• Q33165430 description "scientific article" @default.
• Q33165430 description "teaduslik artikkel" @default.
• Q33165430 description "tieteellinen artikkeli" @default.
• Q33165430 description "tudományos cikk" @default.
• Q33165430 description "vedecký článok" @default.
• Q33165430 description "vetenskaplig artikel" @default.
• Q33165430 description "videnskabelig artikel (udgivet 2015)" @default.
• Q33165430 description "vitenskapelig artikkel" @default.
• Q33165430 description "vitskapeleg artikkel" @default.
• Q33165430 description "vědecký článek" @default.
• Q33165430 description "wetenschappelijk artikel" @default.
• Q33165430 description "wissenschaftlicher Artikel" @default.
• Q33165430 description "επιστημονικό άρθρο" @default.
• Q33165430 description "мақолаи илмӣ" @default.
• Q33165430 description "мақолаи илмӣ" @default.
• Q33165430 description "наукова стаття, опублікована в березні 2015" @default.
• Q33165430 description "научна статия" @default.
• Q33165430 description "научная статья" @default.
• Q33165430 description "научни чланак" @default.
• Q33165430 description "научни чланак" @default.
• Q33165430 description "מאמר מדעי" @default.
• Q33165430 description "سائنسی مضمون" @default.
• Q33165430 description "مقالة علمية" @default.
• Q33165430 description "مقالهٔ علمی" @default.
• Q33165430 description "২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q33165430 description "บทความทางวิทยาศาสตร์" @default.
• Q33165430 description "სამეცნიერო სტატია" @default.
• Q33165430 name "Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial" @default.
• Q33165430 name "Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial" @default.
• Q33165430 name "Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial" @default.
• Q33165430 type Item @default.
• Q33165430 label "Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial" @default.
• Q33165430 label "Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial" @default.
• Q33165430 label "Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial" @default.
• Q33165430 prefLabel "Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial" @default.
• Q33165430 prefLabel "Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial" @default.
• Q33165430 prefLabel "Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial" @default.
• Q33165430 P1433 Q33165430-F31ADA42-0E1C-4D26-97CA-FBDCC66C4F92 @default.
• Q33165430 P1476 Q33165430-0352EB7C-3762-4AEB-8CA3-ECF6AAFE7EA9 @default.
• Q33165430 P2093 Q33165430-0089F9AF-1494-4C66-888D-5A6175AB9546 @default.
• Q33165430 P2093 Q33165430-017C755E-9032-48D1-888F-D553C407AEEA @default.
• Q33165430 P2093 Q33165430-0A26DC83-804D-4EF1-B87F-7A00CE9CD70F @default.
• Q33165430 P2093 Q33165430-0AAEDE48-FA83-4BAF-A427-D58327FBCF69 @default.
• Q33165430 P2093 Q33165430-187BF4C1-AE7A-4DF3-8984-DE38B35918C3 @default.
• Q33165430 P2093 Q33165430-205B15D6-186C-410F-A7A3-51DCC371A3BD @default.
• Q33165430 P2093 Q33165430-370D380D-D993-4FA8-92FE-6DD62055D2D4 @default.
• Q33165430 P2093 Q33165430-38C8CA3A-B49A-4989-92F5-653241525A5D @default.
• Q33165430 P2093 Q33165430-53BF1060-0918-41BA-87B2-3CB6104E6576 @default.
• Q33165430 P2093 Q33165430-548B124C-2EF5-4E26-9F39-1C97BAB28F2F @default.
• Q33165430 P2093 Q33165430-55A8AAF3-BF56-4E84-BF40-11B3E48CE2FB @default.
• Q33165430 P2093 Q33165430-5AFC3F71-7C96-49AD-AB01-733DAA1079C1 @default.
• Q33165430 P2093 Q33165430-76BA4342-2056-422A-9A1D-3F20FCC3564E @default.
• Q33165430 P2093 Q33165430-81CB96AB-959E-424E-98B0-F00352EAF231 @default.
• Q33165430 P2093 Q33165430-826C41ED-D7D3-47E7-8972-C57D66392C41 @default.
• Q33165430 P2093 Q33165430-947F6495-103B-4AE2-9E67-D50917DD2B62 @default.
• Q33165430 P2093 Q33165430-9B2A178F-337D-4E4E-A952-5A974950462D @default.
• Q33165430 P2093 Q33165430-A3076FFA-067E-4952-A4EA-15A70E35373F @default.
• Q33165430 P2093 Q33165430-AAF29932-B2BC-4E30-929E-1DB97A77C0CC @default.
• Q33165430 P2093 Q33165430-B3D2C8E5-4CC9-489F-B8F4-8AFE23041D62 @default.
• Q33165430 P2093 Q33165430-B8126DF7-48AA-4515-B964-FA9F512DE4E8 @default.
• Q33165430 P2093 Q33165430-EE1754B6-F88A-44A0-9230-7BE34BC41304 @default.
• Q33165430 P2860 Q33165430-33CC081C-BA35-404C-A690-85DB1228BA59 @default.
• Q33165430 P2860 Q33165430-38844081-7C63-4FF8-8E3F-8663EA5ABFDA @default.
• Q33165430 P2860 Q33165430-476A1387-D138-460D-BFE1-62E946F9DB12 @default.
• Q33165430 P2860 Q33165430-542F7A13-EFCB-4784-84B4-D5C944E6AB87 @default.
• Q33165430 P2860 Q33165430-5D0D1448-BBF1-433A-BDA0-AE3E53E0F3B9 @default.

• next